ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

PBLA Panbela Therapeutics Inc

1.11
0.00 (0.00%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Panbela Therapeutics Inc PBLA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.11 09:00:00
始値 安値 高値 終値 前日終値
1.11 1.11
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0205:15GLOBEPanbela to Host First Quarter 2024 Earnings Conference Call..
2024/4/3021:00GLOBEAcceptance of Eflornithine (DFMO) Abstract for Oral..
2024/4/2705:39EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
2024/4/2605:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/4/2605:35EDGAR2Form 8-K - Current report
2024/4/2522:09EDGAR2Form 25-NSE - Notification filed by national security..
2024/4/2221:02EDGAR2Form 8-K - Current report
2024/4/2221:00GLOBEPanbela Therapeutics Announces Interim Data Analysis for..
2024/4/1905:31EDGAR2Form S-1 - General form for registration of securities under..
2024/4/1821:00GLOBEPanbela Announces Poster Presentation at American..
2024/4/1721:36EDGAR2Form 8-K - Current report
2024/4/1713:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/4/1706:29GLOBEPanbela Announces Transfer to OTCQB Market
2024/4/0505:17EDGAR2Form DEF 14A - Other definitive proxy statements
2024/3/3006:24EDGAR2Form S-1 - General form for registration of securities under..
2024/3/3006:08EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/3/2705:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/2705:12EDGAR2Form 8-K - Current report
2024/3/2705:10GLOBEPanbela Provides Business Update and Reports Q4 and FY 2024..
2024/3/2620:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
2024/3/2605:15EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/3/1305:15GLOBEPanbela to Host Fourth Quarter and Year End 2023 Earnings..
2024/3/0720:01EDGAR2Form 8-K - Current report
2024/2/1522:05EDGAR2Form 8-K - Current report
2024/2/1522:00GLOBEPanbela Regains Compliance with Nasdaq Listing Standards for..
2024/2/1410:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1407:24EDGAR2Form 8-K - Current report
2024/2/0121:15EDGAR2Form 8-K - Current report
2024/2/0121:00GLOBEPanbela Announces Closing of Approximately $9.0 Million..
2024/1/3107:28EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2024/1/3022:15GLOBEAcceptance of Ivospemin (SBP-101) Abstract for Poster..
2024/1/2920:21EDGAR2Form 8-K - Current report
2024/1/2920:15GLOBEPanbela Announces Pricing of Approximately $9.0 Million..
2024/1/2602:22EDGAR2Form S-1/A - General form for registration of securities..
2024/1/2522:54EDGAR2Form S-1/A - General form for registration of securities..
2024/1/2521:00GLOBEPanbela Exceeds 50% Enrollment for Aspire Trial in..
2024/1/2220:08EDGAR2Form S-1/A - General form for registration of securities..
2024/1/2007:20EDGAR2Form 8-K - Current report
2024/1/1822:15GLOBEPanbela Announces Publication of Clinical Data Titled: Phase..
2024/1/1622:00GLOBEPanbela Announces 1-for-20 Reverse Stock Split Effective..
2024/1/0606:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/2123:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2123:25EDGAR2Form 8-K - Current report
2023/12/2123:15GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
2023/12/2120:00EDGAR2Form 8-K - Current report
2023/12/1822:15GLOBEPanbela Therapeutics Announces US WorldMeds NDA Approval for..
2023/12/0422:00GLOBEPanbela Announces Publication of Abstract Titled: Evaluation..
2023/12/0206:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/0206:15EDGAR2Form 8-K - Current report
2023/11/2922:15GLOBEPanbela Announces 2nd Independent Safety Review of the..

最近閲覧した銘柄

Delayed Upgrade Clock